创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: What are the features of the in vitro killing platform?

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-26 09:56
  • Views:

(Summary description)The InnoModels Biotechnology In Vitro Killing Platform is a leading scientific technology that provides researchers in the fields of biology and drug discovery with an efficient and reliable tool for in vitro experiments. The following are some of the notable features of the platform

InnoModels Biotechnology: What are the features of the in vitro killing platform?

(Summary description)The InnoModels Biotechnology In Vitro Killing Platform is a leading scientific technology that provides researchers in the fields of biology and drug discovery with an efficient and reliable tool for in vitro experiments. The following are some of the notable features of the platform

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-26 09:56
  • Views:
Information

The InnoModels Biotechnology In Vitro Killing Platform is a leading scientific technology that provides researchers in the fields of biology and drug discovery with an efficient and reliable tool for in vitro experiments. The following are some of the notable features of the platform:
1. Diversity of Cell Models: The platform supports many different types of cell models, including tumor cells, immune cells, bacteria, and more. This diversity allows researchers to select the cell type that best suits their research objectives, thus allowing for a more comprehensive assessment of the killing effect.
2. Highly controllable experimental conditions: InnoModels Biotechnology provides researchers with highly controllable in vitro experimental conditions, including the adjustment of media composition, temperature, humidity and other parameters. This helps to ensure the reproducibility of experiments and improve the reliability of research data.
3. Customized experimental design: InnoModels Biotechnology provides customized experimental design services, adapting experimental protocols to the specific needs of researchers to meet the individual requirements of different research projects. This flexibility allows researchers to better explore specific research questions.

 


4. High-throughput experiments: The platform supports high-throughput experiments, allowing multiple samples to be processed at the same time to improve experimental efficiency. This is especially important in areas such as drug screening and disease research.
5. Real-time monitoring and analysis: The platform is equipped with real-time monitoring and data analysis functions, which allow researchers to instantly access the results of experiments and understand the cell killing process in a more timely manner. This helps to adjust the experimental scheme and optimize the experimental design.
6. Highly automated: The company has introduced highly automated technology in the in vitro killing experiment platform to reduce manual operation and improve the consistency and accuracy of the experiment.
7. Strict quality control: InnoModels Biotechnology conducts strict quality control of its in vitro killing experimental platform to ensure the reproducibility of each experiment and the reliability of the results. This helps to guarantee the scientific validity of the research data.
By providing this state-of-the-art in vitro killing assay platform, InnoModels Biotechnology provides advanced tools for life science research and new drug development, and is expected to promote scientists to achieve deeper understanding of cell killing mechanism, drug toxicity and other aspects of research. The application of this technology will provide strong support for drug screening and the development of disease therapies.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司